The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer
 
Honoraria - Clinical Care Options; Medscape; OncLive; Peerview; Research to Practice
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; H3 Biomedicine; Merck; Pfizer; Roche
Research Funding - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; Ignyta; Lilly; Loxo; Merck; PharmaMar; Roche
Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population.
 
Shivaani Kummar
Stock and Other Ownership Interests - Drishti
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Corvus Pharmaceuticals; Genentech; Harbour BioMed; MedTree (I); Mundipharma; Nodus Therapeutics; Seagen; ShangPharma Innovation
Research Funding - ADC Therapeutics (Inst); Advenchen Laboratories (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Dynavax Technologies (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Pfizer (Inst); Plexxikon (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bayer
 
Cornelis M. Van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
Catherine M. Albert
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Bayer Health; Celgene; Clovis Oncology; Cornerstone Pharmaceuticals; Eisai; EMD Serono; Five Prime Therapeutics; Genentech/Roche; ipsen; lsk biopharma; qed therapeutics; Seagen
Research Funding - Bayer (Inst); BeiGene (Inst); boston biomedical (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Loxo (Inst); Macrogenics (Inst); pfizer (Inst); Pharmacyclics (Inst); PsiOxus Therapeutics (Inst); Symphogen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; Bayer; boston Biomedical; EMD Serono; Seagen
Other Relationship - AstraZeneca
 
Anna F. Farago
No Relationships to Disclose
 
Raymond S. McDermott
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche
 
Stefan S. Bielack
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Ipsen; Lilly; Roche; Sensorion
Research Funding - Bayer (Inst); Eisai (Inst); Loxo (Inst)
(OPTIONAL) Uncompensated Relationships - Eisai
 
Francois P. Doz
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Loxo (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Bayer (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
 
Steven G. DuBois
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Ulrik Niels Lassen
Honoraria - Bayer; Pfizer
Consulting or Advisory Role - Bayer; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
 
Serge Leyvraz
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Leo Mascarenhas
Consulting or Advisory Role - Bayer (Inst); Lilly (Inst)
Speakers' Bureau - Bayer
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Lilly (Inst); Loxo (Inst); Salarius Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune (Inst); Bayer (Inst); Lilly (Inst); Salarius Pharmaceuticals; Thermo Fisher Scientific
 
Ramamoorthy Nagasubramanian
No Relationships to Disclose
 
Karen N Keating
Employment - Bayer
 
Costel Chirila
Employment - RTI International
 
Barrett H. Childs
No Relationships to Disclose
 
Theodore Willis Laetsch
Consulting or Advisory Role - Bayer; Lilly; Loxo; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst)
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Lilly; Loxo; MORE Health; Pfizer; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem; Verastem
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena; Presagia
Consulting or Advisory Role - Alphasights; Axiom Biotechnologies; Bayer; Genentech; Gerson Lehrman Group; GroupH; Guidepoint Global; Infinity Pharmaceuticals; Medscape; Merrimack; Numab; Pfizer; PrimE Oncology; Seagen; Takeda; Trieza Therapeutics; WebMD
Research Funding - Abbvie; Adaptimmune; Aldai Norte; Amgen; AstraZeneca/MedImmune; Bayer; Daiichi Sankyo; Fate Therapeutics; Genentech; Infinity Pharmaceuticals; Kite, a Gilead company; Kura Oncology; MedImmune; Mirati Therapeutics; Molecular Templates; National Cancer Institute; Pfizer; Seagen; Shattuck Labs; TCR2 Therapeutics; TP Therapeutics
Travel, Accommodations, Expenses - AACR; ASCO; Bayer Schering Pharma; Genmab; Society for Immunotherapy of Cancer